BLACAT1: A Potential Drug Target and Biomarker (G101669762)

Target Name: BLACAT1

NCBI ID: G101669762

BLACAT1

BLACAT1: A Potential Drug Target and Biomarker

Blastic plasminogen activator (BLAST) is a protein that is involved in the regulation of blood clotting and has been linked to the development of various diseases, including heart disease, cancer, and neurological disorders.BLACAT1, a gene that encodes for a protein known as BLAST, has been identified as a potential drug target and biomarker for several diseases.

BLACAT1 and BLAST: The Interaction

BLACAT1 is a gene that encodes for a protein known as BLAST, which is a member of the plasmin gene family.BLAST is involved in the regulation of blood clotting and has been linked to the development of various diseases, including heart disease, cancer, and neurological disorders.

BLACAT1 gene has been shown to be a key regulator of BLAST expression and has been shown to play a role in the regulation of platelet function and blood clotting. Studies have shown that individuals with certain genetic variations in the BLACAT1 gene are at an increased risk of developing blood clots and other diseases.

Potential Drug Target: BLACAT1

The discovery of BLACAT1 as a potential drug target has significant implications for the treatment of various diseases.BLACAT1 has been shown to be involved in the regulation of blood clotting, which is a critical function for maintaining blood flow to the body's tissues.

Drugs that target BLACAT1 have been shown to be effective in treating various diseases, including heart disease, cancer, and neurological disorders.For example, a drug called ACI-3022 is currently being developed as a treatment for ischemic stroke by targeting BLACAT1.

Biomarker: BLACAT1

BLACAT1 has also been identified as a potential biomarker for several diseases. The levels of BLACAT1 have been shown to be elevated in individuals with certain genetic variations in the gene, which suggests that BLACAT1 may be a useful biomarker for tracking the progression of certain diseases.

Importance of BLACAT1 Research

BLACAT1 research is important for understanding the role of this gene in the regulation of blood clotting and for developing new treatments for various diseases.The discovery of BLACAT1 as a potential drug target and biomarker has significant implications for the treatment of diseases that are currently treated with limited options, such as heart disease, cancer, and neurological disorders.

Conclusion

BLACAT1 is a gene that encodes for a protein known as BLAST, which is involved in the regulation of blood clotting.BLACAT1 has been shown to be a key regulator of BLAST expression and has been linked to the development of various diseases.

Further research is needed to understand the full role of BLACAT1 in the regulation of blood clotting and to develop new treatments for diseases that are currently treated with limited options.

Protein Name: BLACAT1 Overlapping LEMD1 Locus

The "BLACAT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BLACAT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets